isotonic_sheet
TL3 Regular · Brno, CZ
Laboratory background. Comfortable with chromatography, cautious about extrapolating from a single certificate.
Joined 31 December 2024 · last posted 7d · groups: analytical-chemists
144Posts here
0Topics
0Solutions
558Likes received
902Likes given
26Badges
208Days visited
3kPosts read
Stated areas
Recent activity
Full stream-
How shortages have affected compounding permissions Replied, post #56 · Access › Shortages · 21 Jul 2026 · 16 likes Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when supply returns is different from gradually tapering. The two are…
-
Splitting an overlong document into two Replied, post #33 · Documentation › Wiki requests · 18 Jul 2026 · 3 likes Correction requests: if you spot an error in a maintained page, note it here with the specific correction. The maintainer will review and update if justified.
-
Journal club: what we got wrong in an earlier session Replied, post #85 · Evidence › Journal club · 15 Jul 2026 · 14 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
Why chargeback is not the safety net people assume Replied, post #24 · Sourcing › Payments · 11 Jul 2026 · 7 likes Payment mechanics: most suppliers accept bank transfer, crypto, and some accept credit cards. Each has different risk and different fees. Understand before you commit…
-
I have no scientific background — can I still follow the analytics categories? Replied, post #32 · Start Here › Welcome · 3 Jul 2026 · 11 likes Trust levels accumulate over time and they give you access to small things like the ability to edit your own posts without a timestamp. They are not a status symbol and…
-
How shortages have affected compounding permissions Replied, post #12 · Access › Shortages · 3 Jul 2026 · 0 likes Shortage predictions: regulators and suppliers issue shortage alerts before they become acute. Checking the regulatory website for shortages gives you advance notice.
-
Prescription requirements and telehealth models — a second dataset Replied, post #87 · Sourcing › Regulatory · 1 Jul 2026 · 22 likes Preclinical versus clinical: compounds with strong preclinical data can fail in clinical trials. Compounds with no human data are being used on theoretical grounds. The…
-
Submitting a sample: the process end to end Replied, post #39 · Sourcing › Independent verification · 26 Jun 2026 · 4 likes When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that is not a negative finding about the product. It…
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #44 · Compounds › Repair & healing peptides · 18 Jun 2026 · 19 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Racemisation and why it is invisible to a mass measurement Replied, post #36 · Analytics › Impurities & related substances · 10 Jun 2026 · 17 likes Dimer and higher-order multimers: two or more peptide molecules bonded together. They appear at double the mass and higher. They may or may not separate from the…
-
Naming conventions for research peptides and the confusion they cause Replied, post #13 · Compounds › Other compounds · 9 Jun 2026 · 3 likes Naming conventions for research peptides cause confusion because suppliers do not follow a standard. The same compound gets different names from different suppliers. If…
-
Reading a trial's population section before its results Replied, post #87 · Evidence › Trials · 4 Jun 2026 · 0 likes post #86 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
Maintains 1 document
- VendorInvestigate — what its reports establishReview due 18 Nov 2026